· Viridans accounts for more than 50% of streptococci causing infective endocarditis, including nutritionally variant S defectivus and S adjacens
Enterococci ~ 5%S pneumoniae, beta streptococci - rare
Staphylococci: especially post-op or in normal hearts
S aureus ~ 10-15%
Coagulase-negative ~ 10%
HACEK group: 5-10%
· H aphrophilus Actinobacillus, Cardiobacterium hominis, Eikenella Corrodens, Kingella kingae
· Fastidious Gram-negative coccobacilli
Others -5%
· Fungi especially Candida
· Aerobic gram negatives: neonates; line-associated infective
· Coxiella burnetii
Factors Associated with
· Areas of turbulent flow (jet effect, eddies)
· Endothelial disruption
· Sterile fibrin-platelet thrombus development on the abnormal surface
· Entrapment of bacteria from "stray bacteremia" leads to focus of infection
Acute Presentation
· High fever, toxicity
Infective Endocarditis - Evaluation
Three or more blood cultures (separate venipunctures) before therapy
Trans-thoracic echocardiography (-60% sensitive)
Role of trans-esophageal echocardiography is evolving
Duke Criteria
· Incorporate clinical and echocardiographic features
· Major and Minor Criteria
- Definite Infective Endocarditis: Pathologic evidence of IE, or two majors, or one major and 3 minors, or 5 minors
- Possible Infective Endocarditis: Consistent with IE, not definite or rejected
- Rejected Infective Endocarditis: Firm alternate diagnosis, or resolution of illness or absence of evidence of IE at surgery or autopsy after <4 days of antibiotics
- Major Criteria
· Positive blood cultures
* Typical
_ Prolonged, parenteral, bactericidal antibiotics
_ Highly sensitive streptococci (MIC<0.1 mcg/mL)
· Penicillin G or Ceftriaxone 4 weeks
· Penicillin G and Gentamicin 2 weeks
· Vancomycin (for Pen-allergic) 4 weeks
_ Relatively resistant streptococci (MIC >0.1, < 0.5)
· Penicillin G 4 weeks and Gentamicin 2 weeks
· Vancomycin (for Pen-allergic) 4 weeks
_ Enterococci
· Pen G or Ampicillin and Gentamicin 4-6 weeks
· Vancomycin (for Pen-allergic) 4-6 weeks
and Gentamicin